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ow-Dose Computed
omography Coronary
ngiography With
rospective Triggering
Promise for the Future*
hilipp A. Kaufmann, MD
urich, Switzerland
omputed tomography for coronary angiography (CTCA)
as rapidly evolved into a valuable alternative to invasive
oronary angiography for accurate noninvasive assessment
f coronary morphology. Although increasing values of
ositive predictive values are continuously reported, it is
enerally accepted that the strength of this technology at
resent lies in its excellent ability to exclude coronary artery
isease (CAD) (i.e., its high negative predictive value). In
oncordance, most recommendations (1) consider the use of
See page 1450
TCA mainly in low-to-intermediate probability popula-
ions. By its nature, such a population will turn out to have
ow prevalence of CAD and low risk for cardiovascular
vents. Consequently, it is unlikely that any diagnostic or
herapeutic procedure will improve the outcome. Therefore,
he bar seems to be very high for any technique to keep a
ositive balance of harms and benefits. It is in this context
hat the effective radiation dose administered to patients
ndergoing CTCA has evoked an ongoing vivid controversy
n the potential cancerogenic risk of CTCA and its justi-
cation for a purely diagnostic test. This has induced the
earch for strategies to minimize the radiation dose while
aintaining image quality. Several technical advances have
llowed a decrease of the dose from 20 to 25 mSv originally
o about 15 mSv by use of electrocardiogram (ECG)-gated
ube current modulation and even below 10 mSv (2) by
urther optimizing scanning parameters. A recent milestone
n dose reduction for CTCA has been achieved by intro-
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the Department of Nuclear Cardiology, University Hospital Zurich; and thew
urich Center for Integrative Human Physiology (ZIHP), University of Zurich,
urich, Switzerland.ucing prospective ECG triggering, where scanning is
imited to a narrow pre-defined end-diastolic phase result-
ng in a massive reduction in radiation exposure (3).
In this issue of the Journal, Maruyama et al. (4) present
he first results comparing the accuracy of spiral CTCA
ersus prospective triggering computed tomography (CT)
sing invasive quantitative coronary angiography as a stan-
ard of reference. The study included 173 patients, of which
7 underwent spiral CT and 76 were scanned using pro-
pective ECG triggering. The proportion of patients with
n entirely assessable coronary tree was almost identical in
oth groups (i.e., 85% [spiral] and 86% [prospective]). As a
esult, the percentage of assessable segments was 95.5% in
he spiral and 96.6% in the prospective group, confirming
he pioneering first clinical experience of the feasibility of
rospective ECG triggering for CTCA (3). Effective radi-
tion dose was substantially reduced from 21  6.7 mSv to
.3  1.3 mSv. Nevertheless, sensitivity and specificity for
oronary obstructive and occlusive lesions in the assessable
egments by prospective triggering were 96.4% and 98.5%,
omparing well to the 97.0% and 97.6% by helical scan.
hese results underline for the present study population the
oninferiority of the prospective ECG-triggering protocol
ersus the spiral acquisition mode and confirm that the
ormer allows a substantial reduction in effective radiation
ose at no cost of diagnostic accuracy. In the first clinical
eport on prospective triggering, the mean effective radia-
ion dose was lower, averaging 2.1 0.6 mSv most probably
ecause the padding was set at 0 ms, while Maruyama et al.
4) have set it to 30.4 ms. In addition, the present study used
test bolus scan for timing of the scan start after contrast
njection.
Interestingly, in the present study, the nonassessable
egments were mostly due to calcifications while stair-step
rtifacts were not observed. This is in sharp contrast to the
revious first clinical report, where stair-step artifacts ac-
ounted for 46% of nonassessable segments. Several factors
ay have contributed to this: first, the present study
ncluded patients referred for follow-up after coronary
ntervention. This may have lead to a higher prevalence of
AD with more calcifications in this study. Second, al-
hough the administered beta-blocker dose was not exces-
ively high, the heart rate was lower than in previous studies,
hich reduces heart rate variability and lengthens the
otion free diastolic phase. Thus, the applicability of the
resent results to a broad unselected patient population
ust be judged with caution. Another weakness of the study
s that patients were not randomized to the 2 scanning
rotocols, but the decision to switch from spiral scanning to
rospective triggering was taken rather arbitrarily. Thus,
election bias with regard to heart rate and other factors
avoring the latter technique cannot be entirely excluded.
his is underlined by the fact that from 113 patients
ssigned to prospective scanning only 76 were included,
hile from 116 assigned to spiral scanning 97 were in-
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October 28, 2008:1456–7 Prospective Triggering for CTCAluded. A further weakness of the study is that data analysis
as not performed in a blinded fashion. Further, the
alculation of sensitivity and specificity only included the
ssessable segments, overestimating the diagnostic accuracy.
his, however, applies to both scanning protocols. Finally,
he question of which stable patients will benefit most from
TCA was not addressed and must remain unanswered
ith this study—very similar to the question of which
hronic stable CAD patients will benefit most from the
umerous percutaneous coronary interventions per-
ormed every year worldwide despite substantial radiation
nd procedural risks. Interestingly, the authors mention
n the legend of Figure 3 that a moderate stenosis was
reated medically because myocardial perfusion test did
ot reveal ischemia. Unfortunately, no data throughout
he study are provided on the relation of anatomic CTCA
ndings to functional data, although CTCA has recently
een shown to be of comparable value as invasive angiog-
aphy in evaluating the hemodynamic relevance of coro-
ary lesions (5).
In summary, despite some limitations mentioned above
ainly with regards to study design, the results provided by
aruyama et al. (4) represent another important step
orward to reducing effective radiation dose in CTCA and,
hus, to shifting the benefit-to-harm ratio of this technique
o the favorable side of clinical benefit. Even monitoring of
AD therapy with repeat low-dose CTCA may no longer
e considered prohibitive for radiation concerns.
The beauty of prospective triggering lies in its universal
pplicability as it is not limited to the 64-slice scanners but
an be implemented in the latest and future scanner gener- ttions; for example, in those with 320 slices allowing full
overage of the heart in 1 rotation (6). Thus, the concept of
rospective triggering has set new standards and is a
romise for the future.
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